Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.53 |
| ▸ | METAP2 | P50579 | 1/20 | 0.49 |
| ▸ | METAP1 | P53582 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | PNP | P00491 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.41 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.41 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
| ▸ | HPGDS | O60760 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8332576 | 0.86 | RAB9A (0.54) | METAP2METAP1MAPTGRIN2BGSK3B | |
| SCHEMBL10602607 | 0.80 | METAP2 (0.48) | METAP2METAP1KDM4EGRIN2BERBB2 | |
| SCHEMBL5493570 | 0.80 | METAP2 (0.45) | GAAMETAP2METAP1PKMKDM4E | |
| SCHEMBL10303928 | 0.79 | CYP17A1 (0.43) | METAP2METAP1PKMGRIN2B | |
| SCHEMBL27886361 | 0.78 | GAA (0.53) | GAAPKMTSHRKDM4EMAPT | |
| SCHEMBL8806229 | 0.78 | GAA (0.60) | GAAMETAP2METAP1PKMTSHR | |
| SCHEMBL18060062 | 0.77 | HDAC6 (0.42) | GAAPKMKDM4EMAPTTDP1 | |
| SCHEMBL1034656 | 0.77 | GAA (0.51) | GAAPKMTSHRKDM4EMAPT | |
| SCHEMBL27678532 | 0.77 | GAA (0.51) | GAAPKMTSHRKDM4EMAPT | |
| SCHEMBL5440113 | 0.76 | KDM4C (0.47) | METAP2METAP1GRIN2BNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118805676-A | Rapid training method for bird's nest fruits | 海南希源生态农业股份有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-117099578-A | Nutritional propagation method of onion male sterile plant | 兰州龙腾农业科技有限公司 | 2023-11-24 | — | — | CN | claimed |
| EP-3131914-B1 | 3'-SUBSTITUTED METHYL OR ALKYNYL NUCLEOSIDES FOR THE TREATMENT OF HCV | IDENIX PHARMACEUTICALS LLC (US) | 2023-05-10 | — | — | EP | claimed |
| CN-113998653-A | Culture medium subpackaging device and preparation method thereof | 广西壮族自治区农业科学院 | 2022-02-01 | — | — | CN | claimed |
| CN-112913690-A | Peony in-vitro regeneration method | 四川农业大学 | 2021-06-08 | — | — | CN | claimed |
| US-10202411-B2 | 3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV | IDENIX PHARMACEUTICALS LLC (US) | 2019-02-12 | — | — | US | claimed |
| CN-109197582-A | A kind of culture medium of golden flower tea callus bud induction | 罗甸县五湖生态农业旅游开发有限责任公司 | 2019-01-15 | — | — | CN | claimed |
| CN-108935094-A | A kind of bletilla striata cultural method rapidly and efficiently | 贵州发来地农业科技有限公司 | 2018-12-07 | — | — | CN | claimed |
| CN-108935093-A | A kind of bletilla striata tissue culture method primary | 贵州发来地农业科技有限公司 | 2018-12-07 | — | — | CN | claimed |
| CN-108617504-A | A kind of special Initial culture base of candidum tissue culturing seedling and preparation method thereof | 黄振忠 | 2018-10-09 | — | — | CN | claimed |
| CN-1453251-A | Acid liquid fertilizer for drip irrigation and its prepn | INST PROCESS ENG CAS (CN) | 2003-11-05 | — | — | CN | claimed |
| EP-1335920-A2 | SMALL MOLECULE COMPOSITIONS FOR BINDING TO HSP90 | Sloan-Kettering Institute For Cancer Research (US) | 2003-08-20 | — | — | EP | claimed |
| US-6518425-B1 | A process for producing a 1,3-oxathiolane nucleoside comprising reacting a 5-halo-2-protected-oxymethyl-1,3-oxathiolane with a silylated purine or pyrimidine without the addition of a Lewis acid or an additional base to the reaction | EMORY UNIVERSITY | 2003-02-11 | — | — | US | claimed |
| US-20030013880-A1 | Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers | APOTEX PHARMACHEM INC (CA) | 2003-01-16 | — | — | US | claimed |
| WO-2002036075-A2 | SMALL MOLECULE COMPOSITIONS FOR BINDING TO HSP90 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2002-05-10 | — | — | WO | claimed |
| CN-1085042-A | Biocide for protecting cotton bolls and eliminating fusarium wilt of cotton | WANG LIANFANG (CN) | 1994-04-13 | — | — | CN | claimed |
| EP-0562009-A4 | ENANTIOMERICALLY PURE -G(B)-D-(-)-DIOXOLANE-NUCLEOSIDES | — | 1993-11-24 | — | — | EP | claimed |
| EP-0562009-A1 | ENANTIOMERICALLY PURE $g(b)-D-(-)-DIOXOLANE-NUCLEOSIDES | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1993-09-29 | — | — | EP | claimed |
| WO-1992010496-A1 | ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1992-06-25 | — | — | WO | claimed |
| WO-1992010497-A1 | ENANTIOMERICALLY PURE β-D-(-)-DIOXOLANE-NUCLEOSIDES | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1992-06-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030013880-A1 | Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers | SLC29A1, NUDT1, SLC28A1 | GAA 1466/4885METAP2 1203/4885METAP1 572/4885 |
| US-10202411-B2 | 3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV | RB1, NSUN2, METTL3 | GAA 2394/4885METAP2 1396/4885METAP1 2385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.